Copyright Reports & Markets. All rights reserved.

Dynamics in Post-pandemic Global Nicotinamide Mononucleotide (NMN) Industry: Supply and Demand, Markets and Prices 2021-2027

Request for Sample of this report
Buy now

Table of Contents

    1 Product Introduction and Overview

    • 1.1 Product Definition
    • 1.2 Product Specification
    • 1.3 Global Market Overview
      • 1.3.1 Global Nicotinamide Mononucleotide (NMN) Market Status and Forecast (2016-2027)
      • 1.3.2 Global Nicotinamide Mononucleotide (NMN) Sales Value CAGR by Region
    • 1.4 Market Drivers, Inhibitors
      • 1.4.1 Market Drivers
      • 1.4.2 Market Inhibitors
      • 1.4.3 COVID-19 Impact Analysis

    2 Global Nicotinamide Mononucleotide (NMN) Supply by Company

    • 2.1 Global Nicotinamide Mononucleotide (NMN) Sales Volume by Company
    • 2.2 Global Nicotinamide Mononucleotide (NMN) Sales Value by Company
    • 2.3 Global Nicotinamide Mononucleotide (NMN) Price by Company
    • 2.4 Nicotinamide Mononucleotide (NMN) Production Location and Sales Area of Main Manufacturers
    • 2.5 Trend of Concentration Rate

    3 Global and Regional Nicotinamide Mononucleotide (NMN) Market Status by Category

    • 3.1 Nicotinamide Mononucleotide (NMN) Category Introduction
      • 3.1.1 Purity ＜98%
      • 3.1.2 High Purity
    • 3.2 Global Nicotinamide Mononucleotide (NMN) Market by Category
      • 3.2.1 Global Nicotinamide Mononucleotide (NMN) Sales Volume by Category (2016-2021)
      • 3.2.2 Global Nicotinamide Mononucleotide (NMN) Sales Value by Category (2016-2021)
      • 3.2.3 Global Nicotinamide Mononucleotide (NMN) Price by Category (2016-2021)
    • 3.3 North America: by Category
    • 3.4 Europe: by Category
    • 3.5 Asia Pacific: by Category
    • 3.6 Central & South America: by Category
    • 3.7 Middle East & Africa: by Category

    4 Global and Regional Nicotinamide Mononucleotide (NMN) Market Status by End User/Segment

    • 4.1 Nicotinamide Mononucleotide (NMN) Segment by End User/Segment
      • 4.1.1 Health Care Products
      • 4.1.2 Cosmetics
      • 4.1.3 Others
    • 4.2 Global Nicotinamide Mononucleotide (NMN) Market by End User/Segment
      • 4.2.1 Global Nicotinamide Mononucleotide (NMN) Sales Volume by End User/Segment (2016-2021)
      • 4.2.2 Global Nicotinamide Mononucleotide (NMN) Sales Value by End User/Segment (2016-2021)
      • 4.2.3 Global Nicotinamide Mononucleotide (NMN) Price by End User/Segment (2016-2021)
    • 4.3 North America: by End User/Segment
    • 4.4 Europe: by End User/Segment
    • 4.5 Asia Pacific: by End User/Segment
    • 4.6 Central & South America: by End User/Segment
    • 4.7 Middle East & Africa: by End User/Segment

    5 Global Nicotinamide Mononucleotide (NMN) Market Status by Region

    • 5.1 Global Nicotinamide Mononucleotide (NMN) Market by Region
      • 5.1.1 Global Nicotinamide Mononucleotide (NMN) Sales Volume by Region
      • 5.1.2 Global Nicotinamide Mononucleotide (NMN) Sales Value by Region
    • 5.2 North America Nicotinamide Mononucleotide (NMN) Market Status
    • 5.3 Europe Nicotinamide Mononucleotide (NMN) Market Status
    • 5.4 Asia Pacific Nicotinamide Mononucleotide (NMN) Market Status
    • 5.5 Central & South America Nicotinamide Mononucleotide (NMN) Market Status
    • 5.6 Middle East & Africa Nicotinamide Mononucleotide (NMN) Market Status

    6 North America Nicotinamide Mononucleotide (NMN) Market Status

    • 6.1 North America Nicotinamide Mononucleotide (NMN) Market by Country
      • 6.1.1 North America Nicotinamide Mononucleotide (NMN) Sales Volume by Country (2016-2021)
      • 6.1.2 North America Nicotinamide Mononucleotide (NMN) Sales Value by Country (2016-2021)
    • 6.2 United States
    • 6.3 Canada
    • 6.4 Mexico

    7 Europe Nicotinamide Mononucleotide (NMN) Market Status

    • 7.1 Europe Nicotinamide Mononucleotide (NMN) Market by Country
      • 7.1.1 Europe Nicotinamide Mononucleotide (NMN) Sales Volume by Country (2016-2021)
      • 7.1.2 Europe Nicotinamide Mononucleotide (NMN) Sales Value by Country (2016-2021)
    • 7.2 Germany
    • 7.3 France
    • 7.4 UK
    • 7.5 Italy
    • 7.6 Russia
    • 7.7 Spain

    8 Asia Pacific Nicotinamide Mononucleotide (NMN) Market Status

    • 8.1 Asia Pacific Nicotinamide Mononucleotide (NMN) Market by Country
      • 8.1.1 Asia Pacific Nicotinamide Mononucleotide (NMN) Sales Volume by Country (2016-2021)
      • 8.1.2 Asia Pacific Nicotinamide Mononucleotide (NMN) Sales Value by Country (2016-2021)
    • 8.2 China
    • 8.3 Japan
    • 8.4 Korea
    • 8.5 Southeast Asia
    • 8.6 India
    • 8.7 Australasia

    9 Central & South America Nicotinamide Mononucleotide (NMN) Market Status

    • 9.1 Central & South America Nicotinamide Mononucleotide (NMN) Market by Country
      • 9.1.1 Central & South America Nicotinamide Mononucleotide (NMN) Sales Volume by Country (2016-2021)
      • 9.1.2 Central & South America Nicotinamide Mononucleotide (NMN) Sales Value by Country (2016-2021)
    • 9.2 Brazil
    • 9.3 Argentina
    • 9.4 Colombia

    10 Middle East & Africa Nicotinamide Mononucleotide (NMN) Market Status

    • 10.1 Middle East & Africa Nicotinamide Mononucleotide (NMN) Market by Country
      • 10.1.1 Middle East & Africa Nicotinamide Mononucleotide (NMN) Sales Volume by Country (2016-2021)
      • 10.1.2 Middle East & Africa Nicotinamide Mononucleotide (NMN) Sales Value by Country (2016-2021)
    • 10.2 Iran
    • 10.3 Israel
    • 10.4 Turkey
    • 10.5 South Africa
    • 10.8 Saudi Arabia

    11 Sales Channel, Distributors and Buyers

    • 11.1 Sales Channel
      • 11.1.1 Direct Sales
      • 11.1.2 Channel Sales
    • 11.2 Nicotinamide Mononucleotide (NMN) Distributors
    • 11.3 Nicotinamide Mononucleotide (NMN) Buyers

    12 Global Nicotinamide Mononucleotide (NMN) Market Forecast by Category and by End User/Segment

    • 12.1 Global Nicotinamide Mononucleotide (NMN) Sales Volume and Sales Value Forecast (2022-2027)
    • 12.2 Global Nicotinamide Mononucleotide (NMN) Forecast by Category
      • 12.2.1 Global Nicotinamide Mononucleotide (NMN) Sales Volume Forecast by Category
      • 12.2.2 Global Nicotinamide Mononucleotide (NMN) Sales Value Forecast by Category
      • 12.2.3 Global Nicotinamide Mononucleotide (NMN) Price Forecast by Category
    • 12.3 Global Nicotinamide Mononucleotide (NMN) Forecast by End User/Segment
      • 12.3.1 Global Nicotinamide Mononucleotide (NMN) Sales Volume Forecast by End User/Segment
      • 12.3.2 Global Nicotinamide Mononucleotide (NMN) Sales Value Forecast by End User/Segment
      • 12.3.3 Global Nicotinamide Mononucleotide (NMN) Price Forecast by End User/Segment

    13 Global Nicotinamide Mononucleotide (NMN) Market Forecast by Region/Country

    • 13.1 Global Nicotinamide Mononucleotide (NMN) Market Forecast by Region (2022-2027)
      • 13.1.1 Global Nicotinamide Mononucleotide (NMN) Sales Volume Forecast by Region (2022-2027)
      • 13.1.2 Global Nicotinamide Mononucleotide (NMN) Sales Value Forecast by Region (2022-2027)
    • 13.2 North America Market Forecast
    • 13.3 Europe Market Forecast
    • 13.4 Asia Pacific Market Forecast
    • 13.5 Central & South America Market Forecast
    • 13.6 Middle East & Africa Market Forecast

    14 Key Participants Company Information

    • 14.1 GeneHarbor
      • 14.1.1 Company Information
      • 14.1.2 Nicotinamide Mononucleotide (NMN) Product Introduction
      • 14.1.3 GeneHarbor Nicotinamide Mononucleotide (NMN) Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.1.4 Contact Information
    • 14.2 Herbalmax
      • 14.2.1 Company Information
      • 14.2.2 Nicotinamide Mononucleotide (NMN) Product Introduction
      • 14.2.3 Herbalmax Nicotinamide Mononucleotide (NMN) Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.2.4 Contact Information
    • 14.3 Genex Formulas
      • 14.3.1 Company Information
      • 14.3.2 Nicotinamide Mononucleotide (NMN) Product Introduction
      • 14.3.3 Genex Formulas Nicotinamide Mononucleotide (NMN) Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.3.4 Contact Information
    • 14.4 Shandong Sihuan Pharmaceutical
      • 14.4.1 Company Information
      • 14.4.2 Nicotinamide Mononucleotide (NMN) Product Introduction
      • 14.4.3 Shandong Sihuan Pharmaceutical Nicotinamide Mononucleotide (NMN) Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.4.4 Contact Information
    • 14.5 Maac10 Formulas
      • 14.5.1 Company Information
      • 14.5.2 Nicotinamide Mononucleotide (NMN) Product Introduction
      • 14.5.3 Maac10 Formulas Nicotinamide Mononucleotide (NMN) Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.5.4 Contact Information
    • 14.6 Shinkowa Pharmaceutical
      • 14.6.1 Company Information
      • 14.6.2 Nicotinamide Mononucleotide (NMN) Product Introduction
      • 14.6.3 Shinkowa Pharmaceutical Nicotinamide Mononucleotide (NMN) Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.6.4 Contact Information
    • 14.7 Bontac
      • 14.7.1 Company Information
      • 14.7.2 Nicotinamide Mononucleotide (NMN) Product Introduction
      • 14.7.3 Bontac Nicotinamide Mononucleotide (NMN) Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.7.4 Contact Information
    • 14.8 Zhejiang Jiahua Pharmchemical
      • 14.8.1 Company Information
      • 14.8.2 Nicotinamide Mononucleotide (NMN) Product Introduction
      • 14.8.3 Zhejiang Jiahua Pharmchemical Nicotinamide Mononucleotide (NMN) Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.8.4 Contact Information
    • 14.9 EffePharm
      • 14.9.1 Company Information
      • 14.9.2 Nicotinamide Mononucleotide (NMN) Product Introduction
      • 14.9.3 EffePharm Nicotinamide Mononucleotide (NMN) Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.9.4 Contact Information

    15 Conclusion

    Covid-19 has impacted the supply and demand status for many industries along the supply chain. In this report a comprehensive analysis of current global Nicotinamide Mononucleotide (NMN) market in terms of demand and supply environment is provided, as well as price trend currently and in the next few years. This report also includes global and regional market size and forecast, major product development trend and typical downstream segment scenario, under the context of market drivers and inhibitors analysis. According to this survey, the global Nicotinamide Mononucleotide (NMN) market is estimated to have reached $ xx million in 2020, and projected to grow at a CAGR of xx% to $ xx million in 2027.

    Segmented by Category
    Purity ＜98%
    High Purity

    Segmented by End User/Segment
    Health Care Products
    Cosmetics
    Others

    Segmented by Country
    North America
    United States
    Canada
    Mexico
    Europe
    Germany
    France
    UK
    Italy
    Russia
    Spain
    Asia Pacific
    China
    Japan
    Korea
    Southeast Asia
    India
    Australasia
    Central & South America
    Brazil
    Argentina
    Colombia
    Middle East & Africa
    Iran
    Israel
    Turkey
    South Africa
    Saudi Arabia

    Key manufacturers included in this survey
    GeneHarbor
    Herbalmax
    Genex Formulas
    Shandong Sihuan Pharmaceutical
    Maac10 Formulas
    Shinkowa Pharmaceutical
    Bontac
    Zhejiang Jiahua Pharmchemical
    EffePharm
    Buy now